Group One Trading’s PAVmed PAVM Stock Holding History

Group One Trading’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7	Closed	-$144	–	8479
2025 Q1	$144	Buy	+7	New	+$145	﹤0.01%	7390
2023 Q1	–	Sell	-26	Closed	-$5.52K	–	7753
2022 Q4	$5.52K	Sell	26 -45	-63%	-$17K	﹤0.01%	6299
2022 Q3	$27K	Buy	71 +58	+446%	+$32.9K	﹤0.01%	5880
2022 Q2	$6K	Sell	13 -1	-7%	-$483	﹤0.01%	7014
2022 Q1	$8K	Sell	14 -40	-74%	-$29.7K	﹤0.01%	7255
2021 Q4	$60K	Sell	54 -316	-85%	-$687K	﹤0.01%	6180
2021 Q3	$1.42M	Buy	370 +179	+94%	+$564K	﹤0.01%	3016
2021 Q2	$550K	Buy	+191	New	+$451K	﹤0.01%	4113

Other funds holding PAVM

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading's PAVM Position: Q1 2026 in Review

Group One Trading opened a new position in PAVmed (PAVM) in Q1 2026: 2 shares worth $20. The stake represents ﹤0.01% of the portfolio and ranks #7462 among its holdings. This is a return to the name: Group One Trading previously reported a position in PAVM as recently as Q4 2024.

Group One Trading first reported a position in PAVM in Q2 2021 and has held it in 12 quarters since. The position peaked at $599K in Q2 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

Group One Trading held 2 shares of PAVmed worth $20 as of Q1 2026.
PAVmed was a new Group One Trading position in Q1 2026.
PAVmed made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7462 holding.
Group One Trading first reported a position in PAVmed in Q2 2021 and has held it in 12 quarters since.
Group One Trading's PAVmed position peaked at $599K in Q2 2021.
20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.